Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sana Biotechnology Inc (SANA)

Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sana Biotechnology Inc 188 EAST BLAINE STREET SUITE 400 SEATTLE WA 98102 USA

www.sana.com Employees: 194 P: 206-701-7914

Sector:

Medical

Description:

Sana Biotechnology Inc. is focused on creating and delivering engineered cells as medicines for patients. The company involved in repairing and controlling genes, replacing missing or damaged cells as well as making its therapies. Sana Biotechnology Inc. is based in SEATTLE.

Key Statistics

Overview:

Market Capitalization, $K 1,129,392
Enterprise Value, $K 1,001,822
Shares Outstanding, K 266,366
Annual Sales, $ 0 K
Annual Net Income, $ -266,760 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -42,150 K
EBIT, $ -240,000 K
EBITDA, $ -222,610 K
60-Month Beta 1.94
% of Insider Shareholders 30.10%
% of Institutional Shareholders 88.23%
Float, K 186,190
% Float 69.90%
Short Volume Ratio 0.40

Growth:

1-Year Return 46.83%
3-Year Return -10.92%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.15 on 11/06/25
Next Earnings Date 11/14/25 [--]
Earnings Per Share ttm -0.74
EPS Growth vs. Prev Qtr 6.25%
EPS Growth vs. Prev Year 40.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

SANA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -92.70%
Return-on-Assets % -41.33%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.62
Book Value/Share 0.82
Interest Coverage -3.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar